M4K Pharma Blog & News
Our team of dedicated scientists is changing the way childhood diseases are treated. Learn more in our blog and news section about our latest research, open science initiatives, and collaborative efforts aimed at developing affordable treatments.
From 800 Compounds to One Candidate: A Major Milestone in the Fight Against DIPG
Agora Open Science Trust Announces Nomination of M4K2009 as Lead Development Candidate for Pediatric Brain Cancer Therapy
A Conversation with Charlotte Hardy: Advancing Pediatric Brain Cancer Research Through Open Science
Reimagining Drug Development: Moving Beyond Patents
M4K Pharma Receives DMOS Grant to Advance Open Science Drug Discovery for Pediatric Brain Cancer
2024 Research Highlights: Collaborators Receive Funding to Advance Childhood Cancer Research
![Peter Sampson Joins Agora as VP, Drug Discovery and Development [Press Release]](https://images.squarespace-cdn.com/content/v1/6717bbd7aaeae27fa56d0153/1729713119466-GSO8YLVI3ULEVZ1WKCGL/Screenshot+2024-10-23+at+3.51.45%E2%80%AFPM.png)
Peter Sampson Joins Agora as VP, Drug Discovery and Development [Press Release]
M4K Pharma is pleased to announce the appointment of Dr. Peter Sampson as the new Vice President of Drug Discovery and Development for M4K’s parent Canadian charity, Agora Open Science Trust (Agora).
Childhood Cancer Awareness Month
In a piece to mark Childhood Cancer Awareness Month, Dr. Diana Martins Carvalho reflects on the vital support of families who generously donate tissue samples and funds that enable her research into childhood brain tumours.